Sanja Kapitanovic

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Although previously considered rare, recent epidemiological studies have revealed that the incidence (3.6/100,000) and prevalence (35/100,000) of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) has increased over the past few decades. Despite the progress in the understanding of GEP-NET molecular biology, there is still little advance in the early(More)
  • 1